✦ LIBER ✦

Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease

✍ Scribed by Roberts, A. W.; Seymour, J. F.; Brown, J. R.; Wierda, W. G.; Kipps, T. J.; Khaw, S. L.; Carney, D. A.; He, S. Z.; Huang, D. C. S.; Xiong, H.

Book ID: 111981162
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 550 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2011.34.7898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.23 Phase 2 Study of Navitoclax (ABT-26

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results

✍ John F. Seymour; Andrew W. Roberts; Dennis A. Carney; Martin J.S. Dyer; Thomas J 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 71 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

Results of a phase 2 study of valproic a

Results of a phase 2 study of valproic acid alone or in combination with all-transretinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

✍ Andrea Kuendgen; Sabine Knipp; Frank Fox; Corinna Strupp; Barbara Hildebrandt; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 97 KB

A multi-center phase I study of clofarab

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

✍ Hijiya, N; Gaynon, P; Barry, E; Silverman, L; Thomson, B; Chu, R; Cooper, T; Kad 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 248 KB

A phase I and pharmacodynamic study of s

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia

✍ Brenda W Cooper; Erin Donaher; Hillard M Lazarus; Sylvan B Green; David M Gosky; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 863 KB